Luxfer Holdings (LXFR) Q4 2025 earnings call transcript

Now, I will turn the call over to Kevin Grant, Vice President of Investor Relations and Business Development at LUXFER. Kevin, please go ahead.

Thank you, Nikki, and good morning, everyone. Welcome to LUXFER's fourth quarter and full year earnings conference call. This morning, we'll be reviewing LUXFER's financial results for the fourth quarter and full year ended December 31, 2025. I'm pleased to be joined today by Andy Butcher, our Chief Executive Officer, and Steve Webster, our Chief Financial Officer. Today's webcast is accompanied by a presentation that can be accessed at luxford. com.

Please note, any references in non-GAAP financials are reconciled in the appendix of the presentation. Before we begin, a friendly reminder that any forward-looking statements made about the company's expected financial results are subject to future risks and uncertainties. We undertake no obligations to update any forward-looking statements, whether a result of new information, future events, or otherwise. Please refer to the Safe Harbor Statement on slide 2 of today's presentation for further details.

During today's call, we'll be providing adjusted fourth quarter and full year 2025 financial results, excluding the recently sold graphic arts business and 2024 legal recoveries. Now let me introduce Luxford CEO, Andy Butcher. Please turn to slide three. Andy, please go ahead.

Thank you, Kevin, and good morning, everyone. Thank you for joining us. As we close out 2025, I am pleased to describe LUXFER's performance for the year as successful, disciplined, and even better than we expected at the outset. This sustained positive earnings growth reflects the traction of the operating model we have built over the past several years. I am particularly pleased with the way the organisation navigated external pressures during the year, including exchange rate volatility, while continuing to execute at a high level.

For the full year, we again delivered sales growth while maintaining a consistent operating leverage and strong profitability. Adjusted EBITDA totaled $51.9 million, up 4%, and adjusted earnings per share was $1.11, up 12% year-over-year, reflecting our ability to drive earnings through consistent execution and portfolio positioning. We also generated strong free cash flow of $26.2 million and continued to distribute capital to shareholders. Results for the year were driven primarily by sustained momentum in the electron business, particularly across defence and aerospace applications.

Demand for our UGRE and MRE platforms, magnesium aerospace alloys, and certain specialty industrial applications gained in strength as the year progressed and served as a catalyst for full-year results. Indeed, the Magtech Solutions team overcame capacity constraints during the year to deliver record volume levels, including the benefit of an add-on to normal annual demand.

Within gas cylinders, performance reflected variability in certain end markets, including clean energy, healthcare, and first response programs, although again specialty industrial applications showed improvements. Importantly, the team continues strengthening the underlying cost structure and improving operational efficiency.

Across the business, we continued advancing our optimization initiatives, including progress on the Riverside Centre of Excellence and the Powder Saxenburg Centre of Excellence. These initiatives are designed to streamline the footprint, simplify operations, and enhance long-term efficiency. While the financial benefits are expected to begin materialising in late 2026, this year marked meaningful execution progress against these structural priorities.

To summarise, 2025 demonstrated our ability to execute, manage the portfolio effectively, and enhance earnings quality and profitability amid uneven demand conditions, Reinforcing, again, the strength of LUXFER's core operations and value creation strategy.

Finally, as previously communicated and consistent with our focus on long-term shareholder value, following the completion of the accelerated strategic review, the Board has continued to evaluate strategic alternatives. This evaluation remains ongoing. Before turning the call over to Steve, I would like to thank our associates across the organisation for their commitment and execution throughout the year. Their efforts were critical to delivering these results.

With that, I will ask Steve to walk through the fourth quarter and full year financial results in more detail.

Thanks, Andy, and good morning, everyone. Let's turn to slide four for a review of our fourth quarter and full year 2025 consolidated financial results.

Looking at the fourth quarter, adjusted sales were $90.7 million, down 5.5% year over year. As shown in the sales bridge, pricing actions contributed $1.6 million, and foreign exchange provided a $1.1 million tailwind. These positives were more than offset by an $8 million headwind with lower demand in clean energy, automotive, and countermeasure flares.

For adjusted EBITDA, positive pricing was more than offset by the impact of lower volumes, resulting in the reduction from last year's quarter. Despite the lower sales level, adjusted EBITDA for the quarter was $13 million, ahead of our expectations, with an adjusted EBITDA margin of 14.3%. For a full breakdown, please see the detailed waterfall in the appendix on slide 12.

Now, turning to the full year, adjusted sales were $371.2 million, an increase of 2.5%. Adjusted EBITDA totaled $51.9 million, up 4.2%, with an adjusted EBITDA margin of 14%, representing an improvement of 25 basis points compared to 2024.

Adjusted earnings per share were an increase of 12 Cash from operations totaled million supporting a million reduction in net debt to million We ended 2025 at approximately 0.6 times leverage, providing significant balance sheet strength and strategic flexibility.

With that, let's turn to slide 5 for a closer look at Electron's fourth quarter and full year 2025 results.

Turning first to the fourth quarter, sales were $46.9 million, down 1.3% year-over-year, reflecting lower activity in certain select-end markets. Despite the modest reduction in sales, we were pleased that adjusted EBITDA margin remained at a high level of 19.6%, supported by favourable mix and continued focus on higher-value aerospace and defence programmes. For the full year, Electron made a meaningful contribution to overall results. Sales were $196.4 million, up 11.6% versus the prior year, while adjusted EBITDA totaled $36.9 million, an increase of 16%.

Adjusted EBITDA margin expanded to 18.8%, reflecting the continued weighting towards higher margin applications. Full-year performance was supported by sustained demand in magnesium aerospace alloys, which remained a constant contributor throughout 2025. In addition, demand for MRE and UGREs also remained at elevated levels during the year, including the benefit of an add-on to normal annual demand, resulting in record sales volumes. Taken together, these dynamics underscore the earnings power of the Electron business and its ability to perform across varying demand environments.

With that, let's turn to slide 6 for our gas cylinders fourth quarter and full-year 2025 results. Looking at the fourth quarter, sales were $43.8 million, down 9.7% year-over-year, driven primarily by lower SCBA and alternative fuel volumes. Despite the lower sales level, gross margin improved to 17.4%, reflecting favourable mix and operational execution.

Adjusted EBITDA for the quarter was $3.8 million, with profitability holding relatively stable. For the full year, gas cylinders' sales were $174.8 million, down 6.2% versus the prior year, The Ebitda for the year was $15 million, with an adjusted Ebitda margin of 8.6%. While volumes were lower, margins were supported by favorable mix, strong pricing actions, and continued operational efficiencies.

Throughout the year, the business benefited from improved activity in higher-margin specialty industrial applications. which helped offset continued softness in clean energy and variability in healthcare.

Full-year comparisons were also affected by elevated U. S. Air Force deliveries in the prior year. The results for the year included higher legal and operational expenses concentrated in the period, including costs associated with one-off employment-related matters and certain customer accommodations. Overall, gas cylinders 2025 performance reflects solid execution through a period of lower demand, with actions taken during the year positioning the business to deliver higher margins and stronger profitability as volumes improve.

Let's now move to slide 7 for an overview of our 2026 guidance. We expect adjusted sales to be down mid-single digits versus 2025 in a range of $350 to $370 million. The expected year-over-year revenue pressure reflects several timing dynamics, including the expected absence of an MRE add-on, temporary softness in high-end automotive applications, short-term headwinds within space programs, and some pull forward into 2025. That said, we expect continued strength in high margin core aerospace and defense markets. Adjusted earnings per share are expected to be in the range of $1.05 to $1.20, with a midpoint of approximately $1.12. Adjusted EBITDA is expected to be in the range of $50 to $55 million, reflecting continued margin stability and, later in the year, The benefit of action currently underway at our Riverside Centre of Excellence.

Turning to cash and capital deployment, we expect cash flow of approximately $20 to $25 million in 2026. Capsule expenditures are expected to be above normal levels, between $15 and $20 million, primarily supporting optimisation initiatives, growth opportunities, and productivity improvements. We expect a tax rate of approximately 23%, interest expense of $3 to $4 million, and net leverage at approximately 0.7 times.

As previously mentioned, approximately $2 million of orders were pulled forward from quarter one of 2026 into quarter four of last year, ahead of the Pomona to Riverside Optimization Initiative. And we note the equipment moves and commissioning during Quarter 1 will cause inefficiencies.

As a result, combined with normal seasonality and tougher first-quarter comparisons, we expect Quarter 1 earnings to be softer than the prior year.

Regarding FX sensitivity, the average GBP exchange rate in 2025 was approximately 132. Our 2026 planning assumption is 135, which represents an approximate two-cent headwind to earnings on a constant currency basis.

In addition, our 2026 guidance excludes non-recurring advisory costs associated with the Board's ongoing evaluation of strategic alternatives, which we expect to be reflected as one-time expenses during the year. Overall, our outlook reflects thoughtful planning and the structural actions already underway, and we believe we are well positioned to navigate 2026 while maintaining strong margins and a robust balance sheet.

With that, I'll turn the call back to Andy.

Thank you, Steve. Please turn to slide 8. LUXFER remains sharply focused on sustained profitable growth Over the past several years we have strengthened the portfolio streamlined our footprints and reinforced our operating model to perform through the macroeconomic cycles while improving the long earnings profile of the business Our strategy centres on specialised materials engineering, value-added niche applications, and disciplined execution, underpinned by the LUXFER business system, which drives innovation, commercial excellence, and operational rigour.

We expect to deliver steady performance in 2026, supported by core aerospace and defence demands, and the structural actions being implemented across our footprints.

While temporary off-cycle demand shifts moderate short-term growth, our streamlined cost base positions us to convert any incremental volume into improved earnings.

At the same time, we are advancing new product introductions within Electron, including specialised safety and defence-oriented applications, while also launching next-generation gas cylinder products into the SCBA and space arenas.

Looking ahead to 2027, several dynamics are expected to become more favorable. We anticipate the beginning of a new multi-year SCBA replacement cycle, the return of high-end automotive platform activity as model cycles reset, and the potential for another MRE add-on year. Combined with the full benefit of efficiency initiatives already underway, these factors position the business to translate revenue growth into higher profitability.

In short, we believe LUXFER is positioned to navigate 2026 while maintaining margin strength and building toward a more favorable growth environment in 2027.

With that context, I will turn to our closing side to summarize today's key messages. Please turn to slide 9. Our value creation strategy is grounded in disciplined execution while also positioning the business to capitalise on evolving end market trends. In 2025, we delivered another year of earnings growth, margin expansion and strong cash generation, reinforcing the quality of the portfolio. Electron's defence and aerospace platforms were key drivers of performance, demonstrating the strength of our higher value applications.

Gas cylinders navigated programme timing and end market variability while executing pricing actions and continuing to strengthen its cost structure and competitive position. Structural actions across the footprint are beginning to enhance efficiency and position the business to perform through changing macroeconomic conditions and shifting customer demand.

As we look ahead, the headwinds shaping 2026 are primarily timing-related, not structural. As those factors normalise, we see a clear pathway to renewed and accelerated top-line growth and earnings expansion. Overall, we remain confident in LUXFER's positioning, the durability of our earnings profile, and our ability to create long-term shareholder value.

I will now turn the call back to the operator for questions. Nikki, please go ahead.

Yes, thank you, Justin. We were very pleased with our Q4 performance and indeed the 2025 result. There were good demand throughout the year through our more differentiated products, aerospace, defense, especially magnesium alloys, magnesium heaters, specialty oil and gas. All of those supported the strong margins in Electron, along with strong manufacturing output, and led to that adjusted EPS that we saw for the full year up 12% above $1.10.

This is Steve. Good morning. Yeah, I mean, if we look at electron margins, we always talk about an aspirational EBITDA margin of around 20%, and you can see we've been approaching that in 2025, helped by some very strong mix, as Andy has mentioned. I would imagine the margin to continue round about that percent, that 20 percent mark. Clearly, though, the mix can be a bit variable, but I think with the combination of some of the programs we're putting in place in terms of the restructuring programs, a 20 percent margin remains the target, and I think we'll be fairly close to that as we continue throughout the year.

You perhaps hinted there, Justin, this is Andy, about what might drive an upside scenario. So not currently modeled in our guidance, but some of the upsides could come from overperformance in core defense and aerospace, maybe a military add-on for FRH, a busy hurricane season. And on the cost side, of course, we're working on that restructuring project. So if we saw less disruption there or a faster realization of benefits, those would all be potential upsides, not currently included in our guidance.

So we'll be very focused on maximizing the performance in both the business units.

Sure. Yes, thank you. So as a reminder we announced last summer that we would be relocating the aerospace and life support product lines in Pomona California to our Riverside California facility And the savings there are up to $4 million once fully executed.

Right now, we've gone through the equipment moves. Those started in mid-December and will be substantially complete by the end of the quarter. And we're already seeing some initial limited production underway there. The other program is our Electron Powders Center of Excellence, where currently we're operating two manufacturing locations in the U. S. for magnesium powder. And we've identified and are actioning an opportunity there to invest very significantly in our Saxenburg site, over $6 million worth of CAPEX.

That project we also expect to complete before the end of 2026, and the efficiency and automation benefits there are worth around $2 million.

That's included in our guidance.

Yes, so in our electron business, let me give an example of some of our magnesium solutions products during the course of the year. So building on the success of our commercial leg check detection products, we're already putting into the markets now a detection product for organophosphates, And that's planned to be followed later in the year with some detection products around nerve agents such as Novachuk. And then on the cylinders side of the business, we have a range of next generation products. I was lucky enough to visit one of our SCBA customers recently, and they are very excited about the potential of our next generation products there. We've also got a new range being introduced for the space market later in the year.

Yes, so LeadCheck's a relatively small commercial product that's sold through online and through some of the big box stores, And that's used to help people identify lead that might be present in house paint before they go through a restructuring program. So this is small, low million dollars worth of volume, but it's the start of a platform, a range of new products for Magtech Solutions.

Yeah, it's Steve again. I think you'll have seen from the guidance slide that the capital expenditure projection is elevated for 26. We spent around $8 million in 25, which is a little low for us and really represents more sort of maintenance capex. Going into 2026, we're projecting $15 to $20 million. I would say a third of that is down to the restructuring centers of excellence projects that Andy has mentioned. So that's partly the reason for elevated CAPEX. We've also got some exciting growth programs that we're looking to fund as well. So, number one, accelerated or increased capex. Otherwise, certainly in terms of dividend program, that continues at a similar level. We have a normal level of share buyback, which typically runs at around $2.5 million annually.

We would maintain that. We also have an opportunity to do additional opportunistic buybacks should the circumstances arise. We have approval from the board for that. And we also maintain a program of looking at bolt-on type M&A, both centrally with myself and also the business units are tasked with looking at opportunities. So I'd say it's fairly a normal expectation in terms of what we normally do.

Yes, so this is Andy. So we operate an M&A framework that we call SOAR, and that's applied in all of the business units. And they're tasked with looking at a range of synergistic potential M&A activity that would support our overall strategy of profitable growth. But typically, these are bolt-on acquisitions, up to $80 million, I might say.

Thank you, Nikki. LUXFER is well positioned with a durable earnings profile and clear priorities for value creation. Our focus remains on disciplined execution and maximizing shareholder returns. I want to thank our associates for their performance throughout the year, and thank you for your continued support.